MedPath

吉林振澳制药有限公司

Ownership
-
Established
2013-10-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20258011
Approval Date
Jan 26, 2025
NMPA

Ketorolac Trometamol Injection

Product Name
酮咯酸氨丁三醇注射液
Approval Number
国药准字H20249765
Approval Date
Dec 25, 2024
NMPA

Rocuronium Bromide Injection

Product Name
罗库溴铵注射液
Approval Number
国药准字H20243176
Approval Date
Feb 6, 2024
NMPA

Rocuronium Bromide Injection

Product Name
罗库溴铵注射液
Approval Number
国药准字H20243175
Approval Date
Feb 6, 2024
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20243073
Approval Date
Jan 23, 2024
NMPA

Furosemide Injection

Product Name
呋塞米注射液
Approval Number
国药准字H20233896
Approval Date
Jun 30, 2023
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20233677
Approval Date
Jun 7, 2023
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20233667
Approval Date
Jun 7, 2023
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20233215
Approval Date
Feb 21, 2023
NMPA

Cattle Encephalon Glycoside and Ignotin Injection

Product Name
脑苷肌肽注射液
Approval Number
国药准字H22025067
Approval Date
Sep 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.